Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the effectiveness of sublingual administered prostaglandin
E1 synthetic analogue (misoprostol) 400 microgram versus placebo before myomectomy to
decrease blood loss during and after the operation.